Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 173.35K |
Day Range | - - - |
52 Wk Range | 8.08 - 17.80 |
Market Cap | $233.07M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 14.61% |
Days to Cover | 22.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enanta Pharma (NASDAQ:ENTA) through any online brokerage.
Other companies in Enanta Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX) and Genfit (NASDAQ:GNFT).
Enanta Pharma has a consensus price target of $48.92.
The stock price for Enanta Pharma (NASDAQ: ENTA) is $11 last updated September 23, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Enanta Pharma.
Enanta Pharma’s Q4 earnings are confirmed for Monday, November 18, 2024.
There is no upcoming split for Enanta Pharma.
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.